These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Early-Onset Parkinson's Disease With Multiple Positive Intraoperative Spinal Tissue Cultures for Cutibacterium acnes. Mourad M; Passley TM; Purcell JM; Leheste JR Cureus; 2021 Aug; 13(8):e17607. PubMed ID: 34646658 [TBL] [Abstract][Full Text] [Related]
44. Corrigendum: The Challenge of the Pathogenesis of Parkinson's Disease: Is Autoimmunity the Culprit? Jiang T; Li G; Xu J; Gao S; Chen X Front Immunol; 2019; 10():2242. PubMed ID: 31681258 [TBL] [Abstract][Full Text] [Related]
45. Correction to: Molecular mimicry, genetic homology, and gene sharing proteomic "molecular fingerprints" using an EBV (Epstein-Barr virus)-derived microarray as a potential diagnostic method in autoimmune disease. Dreyfus DH; Farina A; Farina GA Immunol Res; 2019 Oct; 67(4-5):460. PubMed ID: 31773489 [TBL] [Abstract][Full Text] [Related]
46. Correction to: Picomolar concentrations of oligomeric alpha-synuclein sensitizes TLR4 to play an initiating role in Parkinson's disease pathogenesis. Hughes CD; Choi ML; Ryten M; Hopkins L; Drews A; BotÃa JA; Iljina M; Rodrigues M; Gagliano SA; Gandhi S; Bryant C; Klenerman D Acta Neuropathol; 2019 Jan; 137(1):121. PubMed ID: 30328509 [TBL] [Abstract][Full Text] [Related]
47. Withdrawal of figure 2 from McNaught and Olanow's article, "Proteasome inhibitor-induced model of Parkinson's disease" (Ann Neurol 2006;60:243-247). McNaught KS; Olanow CW Ann Neurol; 2009 Apr; 65(4):485. PubMed ID: 19399884 [No Abstract] [Full Text] [Related]
48. A different view on the pathophysiology of Parkinson's disease: a descendent neurochemical hypothesis? Yulug B; Ozansoy M; Cankaya S Neural Regen Res; 2019 Oct; 14(10):1717-1718. PubMed ID: 31169187 [No Abstract] [Full Text] [Related]
49. Alpha-Klotho in Parkinson's disease: a perspective on experimental evidence and potential clinical implications. Grillo P; Basilicata M; Schirinzi T Neural Regen Res; 2022 Dec; 17(12):2687-2688. PubMed ID: 35662210 [No Abstract] [Full Text] [Related]
52. Reply: a new look at the pathogenesis of Parkinson's disease. Przedborski S; Vila M; Jackson-Lewis V; Dawson TM Trends Pharmacol Sci; 2000 May; 21(5):165. PubMed ID: 10785645 [No Abstract] [Full Text] [Related]
53. The role of viruses in the pathogenesis of Parkinson's disease. Baizabal-Carvallo JF; Alonso-Juarez M Neural Regen Res; 2021 Jun; 16(6):1200-1201. PubMed ID: 33269775 [No Abstract] [Full Text] [Related]
54. Potential of Tiny RNAs as a Hope to Detect Parkinson's Disease. Kaushik K; Palanichamy JK Ann Indian Acad Neurol; 2020; 23(1):5. PubMed ID: 32055111 [No Abstract] [Full Text] [Related]
55. Microbiology: Gut bacteria linked to Parkinson's. Nature; 2016 Dec; 540(7632):172-173. PubMed ID: 27929009 [No Abstract] [Full Text] [Related]
56. The Pathogenesis of Parkinson's Disease. Sourkes TL Can Med Assoc J; 1963 Jan; 88(1):46. PubMed ID: 20327361 [No Abstract] [Full Text] [Related]
57. The Pathogenesis of Parkinson's Disease. Barbeau A Can Med Assoc J; 1963 Jan; 88(1):46-7. PubMed ID: 20327362 [No Abstract] [Full Text] [Related]
58. Chordoid meningiomas: incidence and clinicopathological features of a case series over 18 years. Di Ieva A; Laiq S; Nejad R; Schmitz EM; Fathalla H; Karamchandani J; Munoz DG; Cusimano MD Neuropathology; 2015 Apr; 35(2):137-47. PubMed ID: 25378105 [TBL] [Abstract][Full Text] [Related]
59. Abnormal neurons in teratomas in NMDAR encephalitis. Day GS; Laiq S; Tang-Wai DF; Munoz DG JAMA Neurol; 2014 Jun; 71(6):717-24. PubMed ID: 24781184 [TBL] [Abstract][Full Text] [Related]
60. The roles of injury and nonsteroidal anti-inflammatory drugs in the development and outcomes of severe group A streptococcal soft tissue infections. Bryant AE; Bayer CR; Aldape MJ; Stevens DL Curr Opin Infect Dis; 2015 Jun; 28(3):231-9. PubMed ID: 25918957 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]